Rare diseases
Investigational molecules
Locations
Study on the Safety and Effects of OMT-28 for Patients with Primary Mitochondrial Disease and Muscle or Heart Problems
GermanyStudy Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer
AustriaStudy on the Effectiveness and Safety of Sodium Cromoglicate for Treating Fatigue in Multiple Sclerosis Patients
SpainStudy of GS-5245 for Treating COVID-19 in Children and Adolescents
BulgariaStudy Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer
BelgiumStudy Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer
BulgariaStudy of Pembrolizumab, Trastuzumab, and Chemotherapy for Patients with HER2 Positive Advanced Stomach or Gastroesophageal Junction Cancer
FranceStudy of NMS-03592088 for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)
FranceStudy on the Effectiveness and Safety of Ocrelizumab, Methylprednisolone, and Diphenhydramine Hydrochloride in Patients with Multiple Sclerosis
BelgiumStudy of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation
CroatiaStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
AustriaStudy on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
